Showing results (131-140 of 359) with videos related to

Sort By:
Pageof 36
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2007
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancerB J Krause, M Souvatzoglou, M Tuncel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancerH Schirrmeister, G Glatting, J Hetzel, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinomaStefanie Hahner, Michael C Kreissl, Martin Fassnacht, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDGAndreas K Buck, Gisela Halter, Holger Schirrmeister, et al.
Neuro-Oncology|December 6, 2013
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patientsKen Herrmann, Johannes Czernin, Timothy Cloughesy, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemiaBernd Neumaier, Felix M Mottaghy, Andreas K Buck, et al.
EJNMMI Physics|November 3, 2020
Performance evaluation of fifth-generation ultra-high-resolution SPECT system with two stationary detectors and multi-pinhole imagingJan V Hoffmann, Jan P Janssen, Takayuki Kanno, et al.
The Prostate|July 21, 2022
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapyPhilipp E Hartrampf, Franz-Xaver Weinzierl, Anna Katharina Seitz, et al.
Theranostics|January 19, 2018
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patientsConstantin Lapa, Malte Kircher, Heribert Hänscheid, et al.
Frontiers in Nuclear Medicine|April 27, 2026
Prognostic impact of discordant lesions on [18F]FDG and [68Ga]Ga-FAPI-04 PET/CT compared to histological FAP expression in neuroendocrine neoplasmsTim Jedamzik, Aleksander Kosmala, Stefan Kircher, et al.
Pageof 36